217 related articles for article (PubMed ID: 11729403)
1. Glyburide/metformin HCl clinical overview.
Seymour A
Manag Care; 2001 Feb; 10(2 Suppl):11-6. PubMed ID: 11729403
[No Abstract] [Full Text] [Related]
2. Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.
Blonde L; Sandberg MI
Diabetes Technol Ther; 2000; 2(3):479-80. PubMed ID: 11467351
[No Abstract] [Full Text] [Related]
3. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.
Dailey GE
Expert Opin Pharmacother; 2003 Aug; 4(8):1417-30. PubMed ID: 12877648
[TBL] [Abstract][Full Text] [Related]
4. Glyburide/metformin (Glucovance) for type 2 diabetes.
Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
[No Abstract] [Full Text] [Related]
5. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
Duckworth W; Marcelli M; Padden M; Kellick K; Duhancik T; Wilhardt M; Colgan K; Romie A
J Manag Care Pharm; 2003; 9(3):256-62. PubMed ID: 14613469
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Garber AJ; Donovan DS; Dandona P; Bruce S; Park JS
J Clin Endocrinol Metab; 2003 Aug; 88(8):3598-604. PubMed ID: 12915642
[TBL] [Abstract][Full Text] [Related]
7. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
Kvapil M; Swatko A; Hilberg C; Shestakova M
Diabetes Obes Metab; 2006 Jan; 8(1):39-48. PubMed ID: 16367881
[TBL] [Abstract][Full Text] [Related]
8. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.
Chien HH; Chang CT; Chu NF; Hsieh SH; Huang YY; Lee IT; Lee WJ; Tang YJ; Sheu WH
J Chin Med Assoc; 2007 Nov; 70(11):473-80. PubMed ID: 18063500
[TBL] [Abstract][Full Text] [Related]
9. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Kellerer M; Jakob S; Linn T; Haslbeck M
MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337
[No Abstract] [Full Text] [Related]
10. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Kahn SE; Haffner SM; Heise MA; Herman WH; Holman RR; Jones NP; Kravitz BG; Lachin JM; O'Neill MC; Zinman B; Viberti G;
N Engl J Med; 2006 Dec; 355(23):2427-43. PubMed ID: 17145742
[TBL] [Abstract][Full Text] [Related]
11. [Type 2 diabetes -- higher doses of metformin improve metabolic control].
Rosak C; Hövelmann R; Martin J
MMW Fortschr Med; 2003 May; 145(21):39. PubMed ID: 12845866
[No Abstract] [Full Text] [Related]
12. Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy.
Hollander P; Sugimoto D; Vlajnic A; Kilo C
J Diabetes Complications; 2015; 29(8):1266-71. PubMed ID: 26281972
[TBL] [Abstract][Full Text] [Related]
13. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Marre M; Howlett H; Lehert P; Allavoine T
Diabet Med; 2002 Aug; 19(8):673-80. PubMed ID: 12147149
[TBL] [Abstract][Full Text] [Related]
14. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.
Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M
Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
[TBL] [Abstract][Full Text] [Related]
16. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.
Dailey GE; Noor MA; Park JS; Bruce S; Fiedorek FT
Am J Med; 2004 Feb; 116(4):223-9. PubMed ID: 14969649
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin: new drug. Type 2 diabetes: limited efficacy, too many unknown risks.
Prescrire Int; 2008 Feb; 17(93):12-5. PubMed ID: 18354861
[TBL] [Abstract][Full Text] [Related]
18. Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
Ali Z; Daniyal M; S I I; Usmanghani K; Naveed S
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1443-9. PubMed ID: 27592478
[TBL] [Abstract][Full Text] [Related]
19. Monitoring safety and effectiveness in patients receiving metformin.
Choe HM; Cornish L; Townsend K; Jobe J; Mitrovich S
Am J Health Syst Pharm; 2004 Aug; 61(15):1550-1. PubMed ID: 15372824
[No Abstract] [Full Text] [Related]
20. Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.
Schwarz SL; Gerich JE; Marcellari A; Jean-Louis L; Purkayastha D; Baron MA
Diabetes Obes Metab; 2008 Aug; 10(8):652-60. PubMed ID: 17941876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
